A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka et al., Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin, Science, vol.307, issue.5708, pp.426-430, 2005.
DOI : 10.1126/science.1097243

D. Luis, D. Sagrado, M. Aller, R. Conde, R. Izaola et al., Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: A contradictory piece of the puzzle, Nutrition, vol.26, issue.11-12, pp.1130-1133, 2010.
DOI : 10.1016/j.nut.2008.11.019

T. Filippatos, C. Derdemezis, I. Gazi, K. Lagos, D. Kiortsis et al., Increased plasma visfatin levels in subjects with the metabolic syndrome, European Journal of Clinical Investigation, vol.115, issue.1, pp.71-72, 2008.
DOI : 10.1111/j.1365-2362.2007.01904.x

P. Saddi-rosa, C. Oliveira, F. Giuffrida, and A. Reis, Visfatin, glucose metabolism and vascular disease: a review of evidence, Diabetology & Metabolic Syndrome, vol.2, issue.1, p.21, 2010.
DOI : 10.1186/1758-5996-2-21

D. Friebe, M. Neef, J. Kratzsch, S. Erbs, K. Dittrich et al., Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans, Diabetologia, vol.3, issue.5, pp.1200-1211, 2011.
DOI : 10.1007/s00125-010-2042-z

T. Filippatos, V. Tsimihodimos, C. Derdemezis, I. Gazi, V. Saougos et al., Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile, Nutrition, Metabolism and Cardiovascular Diseases, vol.23, issue.4, pp.330-336, 2013.
DOI : 10.1016/j.numecd.2011.07.002

K. Kover, P. Tong, D. Watkins, M. Clements, L. Stehno-bittel et al., Expression and Regulation of Nampt in Human Islets, PLoS ONE, vol.318, issue.3, p.58767, 2013.
DOI : 10.1371/journal.pone.0058767.t002

G. Sommer, A. Garten, S. Petzold, A. Beck-sickinger, M. Bluher et al., Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine, Clinical Science, vol.115, issue.1, pp.13-23, 2008.
DOI : 10.1042/CS20070226

S. Jia, Y. Li, J. Parodo, A. Kapus, L. Fan et al., Pre???B cell colony???enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis, Journal of Clinical Investigation, vol.113, issue.9, pp.1318-1327, 2004.
DOI : 10.1172/JCI19930

M. Zhong, H. Tan, H. Gong, S. Wang, Y. Zhang et al., Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis, Clinical Endocrinology, vol.54, issue.6, pp.878-884, 2008.
DOI : 10.1111/j.1365-2265.2008.03248.x

S. Liu, S. Qiao, J. Yuan, and D. Liu, Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans, Clinical Endocrinology, vol.22, issue.2, pp.202-207, 2009.
DOI : 10.1111/j.1365-2265.2008.03453.x

R. Arya, J. Blangero, K. Williams, L. Almasy, T. Dyer et al., Factors of Insulin Resistance Syndrome-Related Phenotypes Are Linked to Genetic Locations on Chromosomes 6 and 7 in Nondiabetic Mexican-Americans, Diabetes, vol.51, issue.3, pp.841-847, 2002.
DOI : 10.2337/diabetes.51.3.841

Y. Zhang, L. Gottardo, R. Thompson, C. Powers, D. Nolan et al., A Visfatin Promoter Polymorphism Is Associated with Low-Grade Inflammation and Type 2 Diabetes*, Obesity, vol.70, issue.12, pp.2119-2126, 2006.
DOI : 10.1038/oby.2006.247

S. Bailey, J. Loredo-osti, P. Lepage, F. J. Fontaine, J. Desbiens et al., Common Polymorphisms in the Promoter of the Visfatin Gene (PBEF1) Influence Plasma Insulin Levels in a French-Canadian Population, Diabetes, vol.55, issue.10, pp.2896-2902, 2006.
DOI : 10.2337/db06-0189

Y. Bottcher, D. Teupser, B. Enigk, J. Berndt, N. Kloting et al., ) and Its Relation to Glucose Metabolism and Fat-Depot-Specific Messenger Ribonucleic Acid Expression in Humans, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.7, pp.2725-2731, 2006.
DOI : 10.1210/jc.2006-0149

C. Oliveira, P. Saddi-rosa, F. Crispim, L. Canani, F. Gerchman et al., Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects, Journal of Diabetes and its Complications, vol.26, issue.2, pp.94-98, 2012.
DOI : 10.1016/j.jdiacomp.2012.02.008

J. Pimenta, L. Zuccherato, A. Debes, L. Maselli, R. Soares et al., Color and Genomic Ancestry in Brazilians: A Study with Forensic Microsatellites, Human Heredity, vol.62, issue.4, pp.190-195, 2006.
DOI : 10.1159/000096872

A. Doria, J. Wojcik, R. Xu, E. Gervino, T. Hauser et al., Interaction Between Poor Glycemic Control and 9p21 Locus on Risk of Coronary Artery Disease in Type 2 Diabetes, JAMA, vol.300, issue.20, pp.2389-2397, 2008.
DOI : 10.1001/jama.2008.649

A. Levey, J. Bosch, J. Lewis, T. Greene, N. Rogers et al., A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, Annals of Internal Medicine, vol.130, issue.6, pp.461-470, 1999.
DOI : 10.7326/0003-4819-130-6-199903160-00002

N. Kadoglou, A. Gkontopoulos, A. Kapelouzou, G. Fotiadis, E. Theofilogiannakos et al., Serum levels of vaspin and visfatin in patients with coronary artery disease???Kozani study, Clinica Chimica Acta, vol.412, issue.1-2, pp.48-52, 2011.
DOI : 10.1016/j.cca.2010.09.012

K. Choi, J. Lee, E. Kim, S. Baik, H. Seo et al., Implication of lipocalin-2 and visfatin levels in patients with coronary heart disease, European Journal of Endocrinology, vol.158, issue.2, pp.203-207, 2008.
DOI : 10.1530/EJE-07-0633

Y. Chang, D. Chang, K. Lin, S. Shin, and Y. Lee, Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review, Diabetes/Metabolism Research and Reviews, vol.382, issue.1-2, pp.515-527, 2011.
DOI : 10.1002/dmrr.1201

K. Segawa, A. Fukuhara, N. Hosogai, K. Morita, Y. Okuno et al., Visfatin in adipocytes is upregulated by hypoxia through HIF1??-dependent mechanism, Biochemical and Biophysical Research Communications, vol.349, issue.3, pp.875-882, 2006.
DOI : 10.1016/j.bbrc.2006.07.083

J. Xiao, B. Sun, M. Li, Y. Wu, and X. Sun, -induced myocardial apoptosis: A missing link between obesity and cardiovascular disease, Journal of Cellular Physiology, vol.4, issue.3, pp.495-501, 2013.
DOI : 10.1002/jcp.24257
URL : https://hal.archives-ouvertes.fr/hal-00908887

S. Lim, S. Davidson, A. Paramanathan, C. Smith, D. Yellon et al., The novel adipocytokine visfatin exerts direct cardioprotective effects, Journal of Cellular and Molecular Medicine, vol.115, issue.4, pp.1395-1403, 2008.
DOI : 10.1111/j.1582-4934.2008.00332.x

D. Hausenloy and D. Yellon, The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion, Journal of Molecular and Cellular Cardiology, vol.35, issue.4, pp.339-341, 2003.
DOI : 10.1016/S0022-2828(03)00043-9

T. Dahl, A. Yndestad, M. Skjelland, E. Oie, A. Dahl et al., Increased Expression of Visfatin in Macrophages of Human Unstable Carotid and Coronary Atherosclerosis: Possible Role in Inflammation and Plaque Destabilization, Circulation, vol.115, issue.8, pp.972-980, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.665893

R. Adya, B. Tan, J. Chen, and H. Randeva, Pre-B cell colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: Role in visfatin-induced angiogenesis, Atherosclerosis, vol.205, issue.1, pp.113-119, 2009.
DOI : 10.1016/j.atherosclerosis.2008.11.024

P. Cirillo, D. Palma, V. Maresca, F. Pacifico, F. Ziviello et al., The adipokine visfatin induces tissue factor expression in human coronary artery endothelial cells, Thrombosis Research, vol.130, issue.3, pp.403-408, 2012.
DOI : 10.1016/j.thromres.2012.06.007

T. Dahl, S. Holm, P. Aukrust, and B. Halvorsen, Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology, Annual Review of Nutrition, vol.32, issue.1, pp.229-243, 2012.
DOI : 10.1146/annurev-nutr-071811-150746

S. Kim, S. Bae, K. Choi, S. Park, H. Jun et al., Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2, Biochemical and Biophysical Research Communications, vol.357, issue.1, pp.150-156, 2007.
DOI : 10.1016/j.bbrc.2007.03.105

B. Goldstein and R. Scalia, Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.6, pp.2563-2568, 2004.
DOI : 10.1210/jc.2004-0518

K. Furukawa, M. Hori, N. Ouchi, S. Kihara, T. Funahashi et al., Adiponectin down-regulates acyl-coenzyme A:cholesterol acyltransferase-1 in cultured human monocyte-derived macrophages, Biochemical and Biophysical Research Communications, vol.317, issue.3, pp.831-836, 2004.
DOI : 10.1016/j.bbrc.2004.03.123

N. Ouchi, S. Kihara, Y. Arita, M. Nishida, A. Matsuyama et al., Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages, Circulation, vol.103, issue.8, pp.1057-1063, 2001.
DOI : 10.1161/01.CIR.103.8.1057

J. Revollo, A. Korner, K. Mills, A. Satoh, T. Wang et al., Nampt/PBEF/Visfatin Regulates Insulin Secretion in ?? Cells as a Systemic NAD Biosynthetic Enzyme, Cell Metabolism, vol.6, issue.5, pp.363-375, 2007.
DOI : 10.1016/j.cmet.2007.09.003

K. Ramsey, J. Yoshino, C. Brace, D. Abrassart, Y. Kobayashi et al., Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD+ Biosynthesis, Science, vol.324, issue.5927, pp.651-654, 2009.
DOI : 10.1126/science.1171641
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2738420

L. Wang, J. Yan, N. Tang, J. Zhu, Y. Wang et al., A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease, Molecular Biology Reports, vol.33, issue.1, pp.819-825, 2011.
DOI : 10.1007/s11033-010-0171-6

K. Leander, B. Gigante, A. Silveira, M. Vikstrom, A. Hamsten et al., NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction, Clinica Chimica Acta, vol.413, issue.7-8, pp.727-732, 2012.
DOI : 10.1016/j.cca.2012.01.002

M. Garcia-bermudez, C. Gonzalez-juanatey, L. Rodriguez-rodriguez, J. Miranda-filloy, S. Perez-esteban et al., Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis, Clin Exp Rheumatol, vol.29, pp.681-688, 2011.

. Saddi-rosa, Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects, Cardiovascular Diabetology, vol.12, issue.1
DOI : 10.1016/j.cca.2012.01.002
URL : https://hal.archives-ouvertes.fr/inserm-00868742